Atlas Trials

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

Clinical trial NCT07078357 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07078357
Sponsor
University of Sao Paulo General Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rheumatic Heart DiseaseRheumatic Heart Disease in ChildrenVaccine Adverse ReactionRheumatic DiseasesVaccine AcceptanceVaccine
Start date
2025-10-01
Primary completion
2027-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.